Annual Current Assets
$25.05 B
+$2.46 B+10.89%
31 December 2023
Summary:
AstraZeneca annual total current assets is currently $25.05 billion, with the most recent change of +$2.46 billion (+10.89%) on 31 December 2023. During the last 3 years, it has risen by +$5.51 billion (+28.19%). AZN annual current assets is now -4.53% below its all-time high of $26.24 billion, reached on 31 December 2021.AZN Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$24.16 B
-$1.24 B-4.88%
30 September 2024
Summary:
AstraZeneca quarterly total current assets is currently $24.16 billion, with the most recent change of -$1.24 billion (-4.88%) on 30 September 2024. Over the past year, it has increased by +$1.65 billion (+7.35%). AZN quarterly current assets is now -11.44% below its all-time high of $27.27 billion, reached on 30 June 2021.AZN Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +10.9% | +7.3% |
3 y3 years | +28.2% | -9.5% |
5 y5 years | +60.7% | +78.7% |
AZN Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -4.5% | +28.2% | -9.5% | +19.4% |
5 y | 5 years | -4.5% | +61.0% | -11.4% | +88.4% |
alltime | all time | -4.5% | +606.3% | -11.4% | +431.1% |
AstraZeneca Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $24.16 B(-4.9%) |
June 2024 | - | $25.39 B(-0.8%) |
Mar 2024 | - | $25.59 B(+2.2%) |
Dec 2023 | $76.06 B(+2.9%) | $25.05 B(+11.3%) |
Sept 2023 | - | $22.50 B(-1.5%) |
June 2023 | - | $22.84 B(+2.6%) |
Mar 2023 | - | $22.27 B(-1.4%) |
Dec 2022 | $73.89 B(-6.6%) | $22.59 B(+11.7%) |
Sept 2022 | - | $20.22 B(-3.3%) |
June 2022 | - | $20.92 B(-7.6%) |
Mar 2022 | - | $22.65 B(-13.7%) |
Dec 2021 | $79.12 B(+67.7%) | $26.24 B(-1.7%) |
Sept 2021 | - | $26.69 B(-2.1%) |
June 2021 | - | $27.27 B(+45.6%) |
Mar 2021 | - | $18.73 B(-4.1%) |
Dec 2020 | $47.19 B(+3.0%) | $19.54 B(+7.6%) |
Sept 2020 | - | $18.17 B(+21.7%) |
June 2020 | - | $14.93 B(+16.4%) |
Mar 2020 | - | $12.82 B(-17.6%) |
Dec 2019 | $45.81 B(+1.7%) | $15.56 B(+15.1%) |
Sept 2019 | - | $13.52 B(-11.2%) |
June 2019 | - | $15.22 B(+11.5%) |
Mar 2019 | - | $13.65 B(-12.5%) |
Dec 2018 | $45.06 B(-10.2%) | $15.59 B(+18.9%) |
Sept 2018 | - | $13.11 B(+5.3%) |
June 2018 | - | $12.45 B(-5.6%) |
Mar 2018 | - | $13.18 B(+0.2%) |
Dec 2017 | $50.20 B(+1.9%) | $13.15 B(-3.5%) |
Sept 2017 | - | $13.63 B(-4.6%) |
June 2017 | - | $14.30 B(+22.9%) |
Mar 2017 | - | $11.64 B(-12.3%) |
Dec 2016 | $49.26 B(+11.8%) | $13.26 B(+3.1%) |
Sept 2016 | - | $12.87 B(-3.4%) |
June 2016 | - | $13.32 B(+4.3%) |
Mar 2016 | - | $12.77 B(-20.2%) |
Dec 2015 | $44.05 B(+5.1%) | $16.01 B(+21.3%) |
Sept 2015 | - | $13.20 B(-4.4%) |
June 2015 | - | $13.81 B(+8.8%) |
Mar 2015 | - | $12.69 B(-24.0%) |
Dec 2014 | $41.90 B(+17.8%) | $16.70 B(+10.8%) |
Sept 2014 | - | $15.07 B(-7.0%) |
June 2014 | - | $16.20 B(-2.0%) |
Mar 2014 | - | $16.54 B(-18.7%) |
Dec 2013 | $35.56 B(+3.1%) | $20.34 B(+8.2%) |
Sept 2013 | - | $18.79 B(-3.1%) |
June 2013 | - | $19.39 B(+5.7%) |
Mar 2013 | - | $18.34 B(-3.7%) |
Dec 2012 | $34.49 B(+17.6%) | $19.05 B(+5.7%) |
Sept 2012 | - | $18.03 B(-8.8%) |
June 2012 | - | $19.78 B(-8.3%) |
Mar 2012 | - | $21.56 B(-8.3%) |
Dec 2011 | $29.32 B(-5.4%) | $23.51 B(+4.6%) |
Sept 2011 | - | $22.47 B(-1.0%) |
June 2011 | - | $22.69 B(-3.3%) |
Mar 2011 | - | $23.47 B(-6.6%) |
Dec 2010 | $31.00 B | $25.13 B(+2.3%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | $24.57 B(+5.1%) |
June 2010 | - | $23.38 B(+4.6%) |
Mar 2010 | - | $22.35 B(-5.9%) |
Dec 2009 | $31.16 B(+0.3%) | $23.76 B(+15.7%) |
Sept 2009 | - | $20.54 B(+7.4%) |
June 2009 | - | $19.13 B(+20.7%) |
Mar 2009 | - | $15.85 B(-0.1%) |
Dec 2008 | $31.08 B(+0.7%) | $15.87 B(+1.9%) |
Sept 2008 | - | $15.57 B(-5.5%) |
June 2008 | - | $16.48 B(+14.0%) |
Mar 2008 | - | $14.45 B(-15.4%) |
Dec 2007 | $30.88 B(+137.6%) | $17.08 B(+16.3%) |
Sept 2007 | - | $14.69 B(-8.6%) |
June 2007 | - | $16.08 B(-1.3%) |
Mar 2007 | - | $16.29 B(-3.8%) |
Dec 2006 | $13.00 B(+17.4%) | $16.94 B(+17.3%) |
Sept 2006 | - | $14.43 B(-4.1%) |
June 2006 | - | $15.05 B(-11.1%) |
Mar 2006 | - | $16.94 B(+23.0%) |
Dec 2005 | $11.07 B(-12.3%) | $13.77 B(+5.2%) |
Sept 2005 | - | $13.10 B(-2.6%) |
June 2005 | - | $13.44 B(-2.4%) |
Mar 2005 | - | $13.77 B(+5.7%) |
Dec 2004 | $12.63 B(+18.7%) | $13.03 B(+6.3%) |
Sept 2004 | - | $12.25 B(+2.9%) |
June 2004 | - | $11.91 B(-10.2%) |
Mar 2004 | - | $13.26 B(+2.5%) |
Dec 2003 | $10.64 B(+12.6%) | $12.93 B(-0.5%) |
Sept 2003 | - | $13.00 B(+6.0%) |
June 2003 | - | $12.27 B(-5.3%) |
Mar 2003 | - | $12.95 B(+6.8%) |
Dec 2002 | $9.45 B(+16.2%) | $12.13 B(+5.2%) |
Sept 2002 | - | $11.53 B(+1.0%) |
June 2002 | - | $11.42 B(-3.0%) |
Mar 2002 | - | $11.77 B(+13.6%) |
Dec 2001 | $8.13 B(+2.6%) | $10.36 B(-7.1%) |
Sept 2001 | - | $11.16 B(+3.6%) |
June 2001 | - | $10.77 B(-5.9%) |
Mar 2001 | - | $11.45 B(+8.8%) |
Dec 2000 | $7.93 B(-20.0%) | $10.52 B(-5.6%) |
Sept 2000 | - | $11.15 B(+8.7%) |
June 2000 | - | $10.25 B(-2.4%) |
Mar 2000 | - | $10.50 B(+5.9%) |
Dec 1999 | $9.90 B(+9.1%) | $9.91 B(-5.2%) |
Sept 1999 | - | $10.46 B(+7.2%) |
June 1999 | - | $9.76 B(+3.8%) |
Dec 1998 | $9.07 B(+154.8%) | $9.40 B(+99.6%) |
June 1998 | - | $4.71 B(-0.2%) |
Dec 1997 | $3.56 B(+5.8%) | $4.72 B(-9.2%) |
Dec 1996 | $3.37 B(+12.0%) | $5.20 B(+6.8%) |
Dec 1995 | $3.01 B(+8.5%) | $4.86 B(+0.5%) |
June 1995 | - | $4.84 B(+6.5%) |
Dec 1994 | $2.77 B(+9.5%) | $4.55 B(-7.1%) |
Dec 1993 | $2.53 B(+4.8%) | $4.89 B |
Dec 1992 | $2.41 B(-6.8%) | - |
Dec 1991 | $2.59 B(+1.5%) | - |
Dec 1990 | $2.55 B | - |
FAQ
- What is AstraZeneca annual total current assets?
- What is the all time high annual current assets for AstraZeneca?
- What is AstraZeneca annual current assets year-on-year change?
- What is AstraZeneca quarterly total current assets?
- What is the all time high quarterly current assets for AstraZeneca?
- What is AstraZeneca quarterly current assets year-on-year change?
What is AstraZeneca annual total current assets?
The current annual current assets of AZN is $25.05 B
What is the all time high annual current assets for AstraZeneca?
AstraZeneca all-time high annual total current assets is $26.24 B
What is AstraZeneca annual current assets year-on-year change?
Over the past year, AZN annual total current assets has changed by +$2.46 B (+10.89%)
What is AstraZeneca quarterly total current assets?
The current quarterly current assets of AZN is $24.16 B
What is the all time high quarterly current assets for AstraZeneca?
AstraZeneca all-time high quarterly total current assets is $27.27 B
What is AstraZeneca quarterly current assets year-on-year change?
Over the past year, AZN quarterly total current assets has changed by +$1.65 B (+7.35%)